Top 50 Biotechnology Startup Investors in Ireland (May 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Enterprise Ireland
VC Fund
|
27 | Ireland, United States, United Kingdom | Seed, Series A | Software, Health Care, Information Technology | $429k–$12M |
|
Kernel Capital
VC Fund
|
9 | Ireland, United Kingdom, France | Seed, Series A | Software, Information Technology, Health Care | $536k–$9M |
|
Western Development Commission
VC Fund
|
8 | Ireland, United States | Seed, Series A | Medical Device, Health Care, Medical | $696k–$8M |
|
Fountain Healthcare Partners
VC Fund
|
6 | Ireland, United States, France | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $3.2M–$55M |
|
AIB Seed Capital Fund
VC Fund
|
6 | Ireland, United States, Jersey | Seed, Series A | Software, Health Care, Medical | $536k–$6.4M |
|
Seroba Life Sciences
VC Fund
|
5 | Ireland, United States, United Kingdom | Series A, Series B | Health Care, Biotechnology, Medical | $1.2M–$37M |
|
Atlantic Bridge
VC Fund
|
4 | United States, Ireland, United Kingdom | Series A, Series B | Software, Information Technology, Artificial Intelligence | $2.5M–$25M |
|
European Investment Bank
VC Fund
|
4 | France, Germany, Ireland | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Software | $6.4M–$536M |
|
Atlantic Bridge University Fund
VC Fund
|
3 | Ireland, United States | Seed, Series A | Medical Device, Health Care, Big Data | $804k–$12M |
|
Irrus Investments
VC Fund
|
3 | Ireland, Sweden, United States | Seed, Series A | Biotechnology, Health Care, Medical Device | $696k–$3.8M |
|
Act Venture Capital
VC Fund
|
3 | Ireland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Analytics | $804k–$13M |
|
The Yield Lab Europe
VC Fund
|
3 | Ireland, United Kingdom, France | Seed, Series A | AgTech, Agriculture, Biotechnology | $536k–$10M |
|
Infinity Capital
VC Fund
|
2 | United States, Ireland, Canada | Series B, Series D | Semiconductor, E-Commerce, Electronics | $4M–$50M |
|
Enterprise Equity
VC Fund
|
2 | Ireland, United States, United Kingdom | Seed, Series B | Software, Information Technology, Medical Device | $536k–$7.5M |
|
SVG Ventures
VC Fund
|
2 | United States, Canada, Ireland | Pre-Seed, Seed | AgTech, Agriculture, Farming | $75k–$6.3M |
|
HealthCap
VC Fund
|
2 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $5.5M–$55M |
|
Lightstone Ventures
VC Fund
|
2 | United States, Ireland, Singapore | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $5M–$95M |
|
HBAN Medtech Syndicate
VC Fund
|
2 | Ireland | Seed, Series B | Medical Device, Medical, Health Care | |
|
John Purdy
Angel
|
1 | Ireland | Seed | Software, FinTech, Medical | $563k–$1.1M |
|
Kreos Capital
VC Fund
|
1 | United Kingdom, Germany, United States | Debt Financing, Series B, Post-IPO Debt | Biotechnology, Health Care, Software | $5M–$85M |
|
Silicon Valley Bank
VC Fund
|
1 | United States, United Kingdom, Canada | Debt Financing, Series B, Series A | Software, Health Care, Biotechnology | $4M–$145M |
|
Claret Capital Partners
VC Fund
|
1 | United Kingdom, Germany, United States | Debt Financing, Series A | Software, Information Technology, Mobile | $1.6M–$32M |
|
The Yield Lab
VC Fund
|
1 | United States, Argentina, Brazil | Seed, Series A, Convertible Note | Agriculture, AgTech, Biotechnology | $50k–$7.2M |
|
MML Capital Partners
VC Fund
|
1 | United Kingdom, France, United States | Private Equity, Series A | Manufacturing, Packaging Services, Food and Beverage | $11M–$20M |
|
Woodford Investment Management
VC Fund
|
1 | United Kingdom, United States, Ireland | Series B, Series A | Biotechnology, Health Care, Medical | $5M–$95M |
|
Furthr VC
VC Fund
|
1 | Ireland | Seed, Pre-Seed | Medical, Medical Device, Health Care | $857k–$3.9M |
|
Ali Partovi
Angel
|
1 | United States, Spain, Israel | Seed, Series A, Angel | Software, Artificial Intelligence, E-Commerce | $175k–$13M |
|
Elkstone Capital Partners
VC Fund
|
1 | Ireland, United Kingdom, United States | Seed, Series A | Software, Medical, Medical Device | $536k–$12M |
|
Eoghan Quigley
Angel
|
1 | Ireland | Seed | Medical, Biopharma, Health Care | |
|
Inventages Venture Capital Investment Inc.
VC Fund
|
1 | United States, United Kingdom, Canada | Series A, Series B | Biotechnology, Health Care, Therapeutics | $2.3M–$19M |
|
Declan Magee
Angel
|
1 | Ireland | Seed | B2B, CRM, SaaS | |
|
WxNW
VC Fund
|
1 | Ireland | Seed | Sales, Consumer, Marketing | |
|
Bpifrance
VC Fund
|
1 | France, United States, Switzerland | Seed, Series A | Software, Health Care, Information Technology | $643k–$29M |
|
Blue Wire Capital
VC Fund
|
1 | United Kingdom, United States, France | Seed, Pre-Seed, Convertible Note | Software, Art, Internet | $550k–$4.3M |
|
Carbery Group
VC Fund
|
1 | ||||
|
Conor Sheahan
Angel
|
1 | Ireland | Seed | Medical, Biopharma, Health Care | |
|
Alimentos Ventures
VC Fund
|
1 | Ireland | Seed | Farming, Aquaculture, Therapeutics | |
|
Moffett Investment Holdings
VC Fund
|
1 | Ireland | Series A, Series B | Medical, Health Care, Biotechnology | |
|
EQT life science
VC Fund
|
1 | United States, The Netherlands, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $5.4M–$70M |
|
Cedas Foundation
VC Fund
|
1 | Ireland, United States | Seed | Biotechnology, Organic, Biopharma | |
|
Medtech Syndicate Nominee
VC Fund
|
1 | Ireland | Seed, Series A | Medical, Health Care, Medical Device | |
|
VisVires New Protein
VC Fund
|
1 | Israel, Germany, The Netherlands | Series A, Series B, Seed | Biotechnology, Food and Beverage, Health Care | $5M–$105M |
|
Wellcome Trust
VC Fund
|
1 | United States, United Kingdom, Germany | Grant, Series C | Biotechnology, Health Care, Pharmaceutical | $1.2M–$90M |
|
Cambridge Innovation Capital
VC Fund
|
1 | United Kingdom, United States, Ireland | Series B, Series A, Seed | Biotechnology, Health Care, Therapeutics | $614k–$61M |
|
KBI Biopharma
VC Fund
|
1 | United States, Ireland | Seed, Series A, Series D | Biotechnology, Life Science, Medical | |
|
Tekla Capital Management
VC Fund
|
1 | United States, Switzerland, France | Series B, Series C, Series A | Biotechnology, Health Care, Therapeutics | $10M–$215M |
|
Street Capital
VC Fund
|
1 | Ireland, United States | Seed | Medical, Automotive, Biotechnology | |
|
ARCH Venture Partners
VC Fund
|
1 | United States, China, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $7M–$230M |
|
Ascentifi
VC Fund
|
1 | Ireland | Series A | Medical Device, Medical, Hospital | |
|
Earlybird Venture Capital
VC Fund
|
1 | Germany, United States, United Kingdom | Series A, Seed, Series B | Software, Information Technology, Health Care | $1.2M–$40M |
| Access all 150 investors in Ireland Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 383
- Round size: Seed $429k–$2.9M; Series A $2M–$12M
- Lead/follow: 15% lead, 85% follow
- Last fund: May invest from a new fund soon — raised $1.1M in 2021
Portfolio highlights
- CergenX — CergenX produces cutting-edge technology for the analysis of baby brain waves that can be used to identify brain injuries early in the newborn period.
- Tailr — Redefining production for the clothing industry.
- Recruitroo — Recruitroo is a international recruitment agency that uses technologies to streamline and improve the international recruitment process for both companies and candidates.
Kernel Capital is the independent manager of The Bank of Ireland Kernel Capital Venture Funds, one of the largest and most active sources of equity finance on the island of Ireland. Kernel leverage their extensive network to enable their portfolio companies recruit the highest caliber people, to break into new international markets and to generaterevenues of scale. It is the only investment firm with venture capital Funds dedicated to both jurisdictions on the Island. Kernel have raised over €210M from investors which including their strategic partner Bank of Ireland, Invest NI, Enterprise Ireland, Galway University Foundation, The University of Limerick Foundation, The New York State Common Retirement Fund and undisclosed Family Offices. Consistently delivering strong financial returns for their investors Kernel have led more than 20 substantial trade sales to NASDAQ, NYSE, and LSE listed corporations.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United Kingdom, France
Investor stats
- Total investments: 86
- Round size: Seed $536k–$4.3M; Series A $1.4M–$9M
- Lead/follow: 50% lead, 50% follow
- Last fund: May invest from a new fund soon — last raise in 2013
Portfolio highlights
- Pretto — Pretto is the only truly transparent online real estate price comparator.Pretto accompanies you until the signing of your loan, free of charge and without commitment.
- Pilot Photonics — Welcome to Pilot Photonics, a laser product development company in Dublin, Ireland. We provide optical frequency combs and tunable lasers.
- Causeway Sensors — The Affinity, is a compact, bench-top Biosensor providing accurate real-time analysis at an accessible price. The Affinity biosensor and accompanying Access Chip incorporate the latest advancements in Nanotechnology, providing the biochemistry researcher the perfect platform to explore the complex world of biomolecular interactions.
Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.
Show more...Investment focus
- Industry: Medical Device, Health Care, Medical
- Stage:Seed, Series A
- Geography: Ireland, United States
Investor stats
- Total investments: 32
- Round size: Seed $696k–$3.8M; Series A $4.7M–$8M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- ByoWave — ByoWave has developed the Proteus Controller, a modular, accessible video game controller for disabled and non-disabled gamers.
- Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
- Amara Therapeutics — Amara Therapeutics is passionate about empowering women and men to take control of their pelvic health. Amara Therapeutics use evidence based medicine and behavioural interventions supported by Amara Therapeutics platform of technologies to provide safe, convenient and non-invasive care pathways. At Amara Therapeutics mission is to fix the carepathway for pelvic health patients, connecting healthcare providers, patients and peers through our platform.
Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: Ireland, United States, France
Investor stats
- Total investments: 40
- Round size: Series A $6.4M–$24M; Series B $5.4M–$48M; Series C $3.2M–$55M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
- Vivasure Medical — Medical device company developing a closure device for vascular access procedures.
- Ermium Therapeutics — Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases, based on a breakthrough discovery showing that CXCR4 is a master regulator of inflammation.
The AIB Seed Capital Fund was established in 2007 to provide venture capital for companies at the seed and early stages of development across a range of sectors throughout the Republic of Ireland. The Fund was established under the Enterprise Ireland Seed and Venture Capital Programme 2007-2012.The Fund has a total of €30m under managementwith AIB and Enterprise Ireland both committing €15m. It is managed by experienced managers with extensive expertise in making seed and early stage investments, adding value and facilitating business success.The Fund managers are empowered to make seed investments of up to approximately €500,000. Furthermore, the Fund has the capacity to make investments in later rounds to support the continued growth of investee companies.The Fund will be managed by Enterprise Equity Venture Capital and the Dublin Business Innovation Centre. This unique partnership brings together extensive regional and investment expertise.Enterprise Equity will evaluate and manage all investments outside the city and county of Dublin, as well as investments that require in excess of €250,000 from the fund within the city and county of Dublin.Dublin Business Innovation Centre (DBIC) will evaluate and manage all investments within the city and county of Dublin when the initial investment amount required from the Fund does not exceed €250,000.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Series A
- Geography: Ireland, United States, Jersey
Investor stats
- Total investments: 49
- Round size: Seed $536k–$3.2M; Series A $1.1M–$6.4M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- NewsWhip — The only real-time media monitoring platform that predicts the stories and topics that will matter in the hours ahead.
- Offr — Offr is the new way to buy and sell property, quickly and transparently.
- Metabolomic Diagnostics — https://metabolomicdiagnostics.com/ A deep-tech company specialized in the development of biomarker-based diagnostic solutions
Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning biotech innovations.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 35
- Round size: Series A $1.2M–$24M; Series B $4.6M–$37M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
- Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
- Storm Therapeutics — Targeting pathways that modify RNA to deliver novel cancer therapeutics.
Atlantic Bridge is a growth equity technology Fund with offices in Dublin, London, Palo Alto, Beijing, and Hong Kong. They focus on Middle Market Technology investments across Europe, with a strong emphasis on a transatlantic business building and investment exit model. We focus on making domain-specific investments in growth-stage companies,specifically in sectors such as Artificial Intelligence, Machine Learning, Robotics, Computer Visioning, IoT, Big Data, etc.Atlantic Bridge brings together a unique team of technology entrepreneurs, experienced managers, finance professionals, and investment experts. The team contains a wealth of international business experience across Europe, the US, and Asia. They have worked together in various capacities for the last 30 years, bringing a true partnership approach to their firm and their investments. Its investors include the founders, leading institutional investors, and private investors with a track record of investment in successful technology companies.Atlantic Bridge has developed a unique and differentiated strategy that focuses on specific technology themes and the implementation of the “Atlantic Bridge Model” for scaling companies internationally. The “Bridge Model” accelerates the scale-up of technology companies in the US and Chinese markets. This approach is highly differentiated and has delivered strong performance results to date.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B
- Geography: United States, Ireland, United Kingdom
Investor stats
- Total investments: 110
- Round size: Series A $5M–$25M; Series B $2.5M–$22M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $86M in 2021
Portfolio highlights
- Mitiga — Mitiga proactively stores and enhances forensic data so our experts can start incident investigations fast to get you back to business as usual
- Oblivious — Oblivious builds tools to allow you to use your sensitive data with internal and external partners while keeping it private and secure.
- Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union.The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds;equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds.The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises.EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors.European Investment Bank was founded in 1958 and is based in Luxembourg.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Debt Financing, Post-IPO Debt
- Geography: France, Germany, Ireland
Investor stats
- Total investments: 202
- Round size: Post-IPO Debt $6.4M–$536M; Debt Financing $11M–$321M
- Lead/follow: 78% lead, 22% follow
Portfolio highlights
- Valmet — Valmet is the leading global developer and supplier of technologies, automation and services for the pulp, paper and energy industries.
- CTP — CTP NV is a real estate company that owns and develops industrial and logistics parks.
- Cofina Ivory — Cofina Ivory is a savings and credit institution that operates in the sector of mesofinance.
We invest in entrepreneurs with the ambition to create world-class companies of scale.
Show more...Investment focus
- Industry: Medical Device, Health Care, Big Data
- Stage:Seed, Series A
- Geography: Ireland, United States
Investor stats
- Total investments: 28
- Round size: Seed $804k–$3.8M; Series A $3.1M–$12M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
- ProVerum Medical — ProVerum Medical is an early stage medical device startup for the treatment of Benign Prostatic Hyperplasia (BPH).
- Tympany Medical — Tympany Medical is a Needs-driven, Innovative MedTech StartUp based in the West of Ireland
Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Seed, Series A
- Geography: Ireland, Sweden, United States
Investor stats
- Total investments: 19
- Round size: Seed $696k–$3.8M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
- ByoWave — ByoWave has developed the Proteus Controller, a modular, accessible video game controller for disabled and non-disabled gamers.
- Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Technology-focused, investing capital and expertise to fuel growth in the most promising ideas and companies. Raised c.€600m across multiple funds and invest from seed to growth.We look for companies with potentially cutting-edge, category-defining businesses in markets including application software, IT infrastructure, communications, Internetand mobile. We help founders create and scale businesses globally. We work as a small team with diverse strengths accessing a community of over 200 founders. The teams and companies we back scale their investor base as they scale their business execution and ambition. We work closely with them in this process. Over the past 25 years have built a broad network of US and European investors and founders that share our vision and approach.Act is based in Dublin, Ireland.Our most recent funds are supported by the European Investment Fund.
Show more...Investment focus
- Industry: Software, Information Technology, Analytics
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 132
- Round size: Seed $804k–$3.3M; Series A $2.4M–$13M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Oblivious — Oblivious builds tools to allow you to use your sensitive data with internal and external partners while keeping it private and secure.
- Everyangle — Everyangle facilitates business in computer vision applications based on cisco meraki MV smart cameras across retail and industrial firms.
- Spectrum Life — Spectrum.Life's comprehensive solution enables organisations to provide a workplace wellbeing programme that can have a substantially positive impact on their health and wellness, as well as on the culture and performance of the company.
The Yield Lab Europe is a €50m early stage Agrifood and Ag Tech fund which comprises an accelerator and a larger follow-on fund, investing in high tech companies with the potential to significant disrupt and improve our current systems of global food production, and to improve the environmental sustainability of the industry. The main fund invests€1m each into 10-12 companies over several follow on rounds, with the strongest accelerator companies expected to progress to the main fund. The Yield Lab Europe is also part of a global network of Agrifood Tech funds, with global headquarters in St Louis USA, and sister funds in LATAM and Singapore.
Show more...Investment focus
- Industry: AgTech, Agriculture, Biotechnology
- Stage:Seed, Series A
- Geography: Ireland, United Kingdom, France
Investor stats
- Total investments: 27
- Round size: Seed $536k–$2M; Series A $3.8M–$10M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — raised $54M in 2021
Portfolio highlights
- Skytree — Transforming Carbon Removal for stable, reliable and sustainable CO2 supply
- BiOceanOr — BiOceanOr provides underwater weather stations to measure water quality. Their solutions provide informations from your exploitation in real-time. Receive alerts in real-time and take decisions with their preventive alert system.
- Solasta Bio — Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection.
Infinity Capital are hypothesis-driven investors - constantly calibrating ideas through a Silicon Valley/technology network that they've been building for over two decades. Their extensive technology and operating backgrounds, combined with over a dozen years each of successful startup investing, have been essential in buildingcredibility and a reputation that resonates with entrepreneurs.
Show more...Investment focus
- Industry: Semiconductor, E-Commerce, Electronics
- Stage:Series B, Series D
- Geography: United States, Ireland, Canada
Investor stats
- Total investments: 33
- Round size: Series B $9M–$50M; Series D $4M–$17M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- AltraTech — Next Generation Molecular Detection Discover Altratech Next Generation Molecular Detection Discover Altratech At Altratech, our mission is to enable next generation molecular detection.
- BioSapien — BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline ofindications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life.
- Core Starters — Core Starters services startups and investors through blockchain-based decentralized services to solve real problems.
Enterprise Equity (or EEVC) is an excellent for providing capital to early stage and expanding business throughout Ireland.
Show more...Investment focus
- Industry: Software, Information Technology, Medical Device
- Stage:Seed, Series B
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 51
- Round size: Seed $536k–$2.1M; Series B $2.5M–$7.5M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Phorest — Join 8000+ spas, barbers, hair, beauty and nail salon owners using the #1 management, scheduling, POS and appointment booking system. Try Phorest now!
- SurgaColl — SurgaColl Technologies is a medical device company developing novel tissue regeneration products for the surgical treatment of diseases of the bone, cartilage and other human tissue. Based on technology developed at the Tissue Engineering Research Group (TERG) of the Royal College of Surgeons in Ireland (RCSI), headed by Professor Fergal O’Brien,the company aims to become a leader in the field of regenerative medical devices.
- Metabolomic Diagnostics — https://metabolomicdiagnostics.com/ A deep-tech company specialized in the development of biomarker-based diagnostic solutions
We work with leading corporations, startups, universities, and growers to solve the biggest challenges facing the agtech and foodtech industries.
Show more...Investment focus
- Industry: AgTech, Agriculture, Farming
- Stage:Pre-Seed, Seed
- Geography: United States, Canada, Ireland
Investor stats
- Total investments: 86
- Round size: Seed $100k–$6.3M; Pre-Seed $75k–$100k
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- FarmWise — FarmWise provides technology-based services that allow farmers to streamline farm operations and increase food production efficiency.
- Food4All — With the F4A App, you can explore discounted close-to-expiry products at your favourite supermarkets. Act now - save money and say no to food waste.
- Napigen — We are the genome editing company specialized for mitochondrial engineering. We address unmet needs of future food supplies by creating hybrid crop plants to boost their yields to an unprecedented level. The company’s technology creates robust male sterile lines that are ideal over conventional lines because of their stability and elitebackgrounds. This allows the production of non-GM hybrid seeds in crop plants that are currently mostly non-hybrid such as wheat. Our technology solution is expected to fulfill the highest level of public acceptance and aspiration.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 109
- Round size: Series A $5.5M–$55M; Series B $20M–$54M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Hemab — Hemab is pioneering the first preventative treatments and functional cures for patients with rare bleeding and thrombotic disorders.
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- Vicore Pharma — Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, Ireland, Singapore
Investor stats
- Total investments: 64
- Round size: Series A $5M–$95M; Series B $7.5M–$90M; Series C $20M–$73M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Nimbus Therapeutics — Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company. Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinicaldevelopment. We are designing highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer and immune-inflammatory disorders.
- Relievant Medsystems — Relievant's mission is to provide patients with low risk therapy that can alleviate their back pain.
- Tagworks Pharmaceuticals — As pioneers of Click-to-Release technology, we are revolutionizing cancer treatment using in vivo click chemistry to increase the therapeutic window of powerful cancer therapies.
HBAN Medtech Syndicate
Show more...Investment focus
- Industry: Medical Device, Medical, Health Care
- Stage:Seed, Series B
- Geography: Ireland
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- Deciphex — Deciphex - Transforming Digital Pathology - we are focussed on the development of applications for clinical and veterinary pathology that improve productivity
- Signum Surgical — Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.
- Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
John Purdy
Show more...Investment focus
- Industry: Software, FinTech, Medical
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 3
- Round size: Seed $563k–$1.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- dimply — The experience & engagement platform for financial enterprises.
- Beyondbmi — Beyondbmi is an expert led medical approach to weight loss. We provide a convenient and scientific telehealth program designed to help your reach your health goals.
- FlowForma — Unlock competitive advantage with FlowForma, the #1 no code digital process automation software & business process management tool. Get a free trial now!
Kreos Capital provides innovative and flexible debt solutions to equity-backed, pan-European and Israeli high-growth companies in the technology and healthcare sectors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Debt Financing, Series B, Post-IPO Debt
- Geography: United Kingdom, Germany, United States
Investor stats
- Total investments: 127
- Round size: Series B $8M–$85M; Post-IPO Debt $5M–$21M; Debt Financing $5M–$70M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Qover — Plug & play solutions empowering any digital business to integrate insurance into its strategy. Our promise? A tailored insurance experience, right when your customers need it most.
- Abivax — Abivax recently presented impressive 9-month interim extension data from studies of ABX464 in ulcerative colitis during an oral presentation at DDW 2019, demonstrating a continued duration of beneficial effect in patients after 11-months of treatment. View the conference presentation, here:
- Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Silicon Valley Bank works with technology, life science, cleantech, venture capital, private equity, and premium wine businesses. SVB provides industry knowledge and connections, financing, treasury management, corporate investment, and international banking services to its clients worldwide through 27 U.S. offices and seven internationaloperations. Banking innovative companies and exclusive wineries, Silicon Valley Bank’s diverse financial services, knowledge, global network, and world-class service increase its clients’ probability of success. Forbes Magazine ranks SVB among America’s Best Banks, and Fortune Magazine named SVB one of the Best Companies to Work For in 2012.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Debt Financing, Series B, Series A
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 374
- Round size: Series A $4M–$30M; Series B $5.5M–$42M; Debt Financing $5M–$145M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- SafeRide Health — SafeRide Health provides technology-forward non-emergency medical transportation (NEMT) services for care providers and health plans offering Medicare Advantage and Medicaid. We intelligently improve and simplify NEMT to improve health outcomes and healthcare satisfaction.
- Rainforest — Rainforest focuses on providing software platforms for payment processing. Rainforest is headquartered in Atlanta, United States.
- Olema Oncology — At Olema Oncology, we leverage our deep understanding of endocrine-driven cancers, nuclear receptors and mechanisms of acquired resistance with the goal of transforming the standard of care for women living with cancer by focusing on developing more convenient and effective therapies. Join us as we aim to design therapies for improving lives.
Claret Capital provides specialty debt financing to European growth businesses, predominantly in the technology, life sciences and environmental sectors. Typical loan sizes range from €1M-€40M with the flexibility to do larger transactions opportunistically.They look for investment opportunities in high growth business with proven managementteams in need of capital to fuel organic growth, acquisitions, equipment purchases, bridge loans and various forms of recapitalization.
Show more...Investment focus
- Industry: Software, Information Technology, Mobile
- Stage:Debt Financing, Series A
- Geography: United Kingdom, Germany, United States
Investor stats
- Total investments: 89
- Round size: Series A $2M–$6M; Debt Financing $1.6M–$32M
- Lead/follow: 18% lead, 82% follow
- Last fund: Likely still investing — raised $318M in 2022
Portfolio highlights
- Abivax — Abivax recently presented impressive 9-month interim extension data from studies of ABX464 in ulcerative colitis during an oral presentation at DDW 2019, demonstrating a continued duration of beneficial effect in patients after 11-months of treatment. View the conference presentation, here:
- Holidu — Holidu is a search engine for vacation rentals. Search and compare more than 15 million vacation homes and save up to 55% on identical accommodations.
- Exoticca — Exoticca develops an online platform intended to facilitate travel booking. The company's platform offers holiday packages which includes flights, accommodation, meals, guides and private transports, for exotic locations all around the world, enabling travelers to book travel packages online at competitive prices.
The Yield Lab invests in AgriFood Tech companies with technologies focused on crops, animal health, digital agriculture, logistics, and food ingredients. Initial investments range from $100,000 – $1.5M.
Show more...Investment focus
- Industry: Agriculture, AgTech, Biotechnology
- Stage:Seed, Series A, Convertible Note
- Geography: United States, Argentina, Brazil
Investor stats
- Total investments: 54
- Round size: Seed $100k–$4M; Series A $950k–$7.2M; Convertible Note $50k–$1.2M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $50M in 2022
Portfolio highlights
- Seedz — Seedz is a platform that brings farmers, resellers, rural producers, and agricultural entrepreneurs together boost agri - industry.
- Pure Ocean Algae — Pure Ocean Algae is a biotechnology company that integrates value chains from macro-algae and other marine resources. The company has over the winter of 2019/20 deployed its first trial lines of Palmaria palmata to sea, with initial results being extremely positive. It has also taken primary research in tank-based vegetative production andsucceeded in developing a pilot commercial plant that can produce commercial volumes of Palmaria palmata, at levels approaching 100% per week.
- Ascribe Bioscience — Ascribe develops natural crop protection products that help farmers reduce disease and increase yield without harming the environment or human health.
MML Capital Partners is an independent investment firm, with over twenty years of history, focused on providing capital to businesses for expansion/acquisitions, management-led equity deals, recapitalisations and buy-outs.
Show more...Investment focus
- Industry: Manufacturing, Packaging Services, Food and Beverage
- Stage:Private Equity, Series A
- Geography: United Kingdom, France, United States
Investor stats
- Total investments: 26
- Round size: Private Equity $11M–$20M
- Lead/follow: 77% lead, 23% follow
- Last fund: Likely still investing — raised $718M in 2021
Portfolio highlights
- Global Packaging Services — Reusable metal crate multi-way packaging solutions, reusable metal crate multi-way packaging solutions.
- Ross-shire Engineering — Engineered Solutions for the Treatment & Purification of Water from RSE (Ross-shire Engineering).
- Virginia International Logistics — Virginia International Logistics provides temperature controlled, dry freight, and containerized logistics across Ireland, UK and Europe.
Woodford Investment Management is a privately owned investment firm manages equity mutual funds. At Woodford, they don’t want to be just another fund management company. They want to create something different and better for their investors and they feel strongly that existing and potential clients are entitled to understand what they are doingwith their money.As investors, they are active, engaged, long-term, disciplined, diligent and focused. That’s a lot of things to say about their selves but each word is important in helping you to understand how they manage money – they will explain in more detail as they move along.Their investment approach and process are focused on value discovery, not price discovery. They believe that financial markets are inherently inefficient and that, through disciplined and diligent analysis, they can identify investment opportunities where market prices do not reflect long-term fundamental value. By exploiting this pervasive market characteristic, they believe they can create real long-term value for their investors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 62
- Round size: Series A $5M–$95M; Series B $9.8M–$53M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Inivata — Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and their patients.Unlike conventional invasive biopsies, Inivata detects and analyses genomic material from a cancer patient’s cell-free, circulating tumor DNA (ctDNA) which can be collectedthrough a simple blood sample. This non-invasive approach – a liquid biopsy – offers a revolution in how cancer is detected, monitored, and treated.
- Revolut — Open a free account in minutes right from your phone, and make your money go further
- Atom Bank — Savings accounts, a range of mortgages & business loans, you'll find it all with Atom bank. App-based and designed to be hassle-free. Download the app today.
Furthr VC invests in transformative tech. Furthr Venture Capital invests in scalable, early-stage companies. We help Ireland's next generation of technology.
Show more...Investment focus
- Industry: Medical, Medical Device, Health Care
- Stage:Seed, Pre-Seed
- Geography: Ireland
Investor stats
- Total investments: 12
- Round size: Seed $857k–$3.9M
- Lead/follow: 58% lead, 42% follow
- Last fund: May invest from a new fund soon — raised $34M in 2019
Portfolio highlights
- Klearcom — Klearcom tests the full customer call path from domestic phone number through the IVR Interactive Voice Response for connectivity and voice quality, validating voice call paths ensuring the connection between customer and agent is always reachable and accessible, software telecommunications IVR testing voice
- UrbanFox — UrbanFox protects online retailers against new forms of stealth fraud by analysing and learning from existing legitimate and fraudulent customer behavioural patterns.
- Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
Ali Partovi is the CEO and Founder of Neo and was a Founding partner at linkexchange. Ali attended Harvard University.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, E-Commerce
- Stage:Seed, Series A, Angel
- Geography: United States, Spain, Israel
Investor stats
- Total investments: 64
- Round size: Seed $800k–$4M; Angel $175k–$1M; Series A $800k–$13M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Zentail — All in one SaaS platform for Multi-Channel Online Retailers.
- Expedock — Delivering Powerful Data Infrastructure for the Global Supply Chain. Experience AI technology that streamlines all logistics workflows with Expedock.
- Skiff — Everything on Skiff is end-to-end encrypted. Your most sensitive data is private, decentralized, and truly owned by you.
Elkstone Capital Partners is a multi-family office focused on venture, real estate and wealth management.
Show more...Investment focus
- Industry: Software, Medical, Medical Device
- Stage:Seed, Series A
- Geography: Ireland, United Kingdom, United States
Investor stats
- Total investments: 46
- Round size: Seed $536k–$2.8M; Series A $6.2M–$12M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Mesh — The ONLY Email Security Platform purpose-built for MSPs with Best-In-Class Machine Learning Powered Detection, and a revolutionary centralized management console (MSP Hub)
- Manna Drone Delivery — Drone delivery made simple
- Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
Eoghan Quigley
Show more...Investment focus
- Industry: Medical, Biopharma, Health Care
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Beyondbmi — Beyondbmi is an expert led medical approach to weight loss. We provide a convenient and scientific telehealth program designed to help your reach your health goals.
Inventages Venture Capital Investment Inc is an investment arm of Nestle SA specializing in PIPES, seed, early, mid, and late venture investments. The firm seeks to invest in middle market and mature companies. It provides mezzanine and bridge financing. The firm seeks to invest in health care, life sciences, cosmeceuticals, pharmaceuticals,enabling technologies and services, and diagnostic and medical devices. Within the pharmaceutical sector, it typically invests in small molecules, proteins, antibodies, vaccines, phytopharmaceuticals, natural compounds, botanicals, antibiotics, and therapeutics. Within the diagnostic sector, it focuses on genetic materials, biomarkers, pathological markers, genetic profiles, protein profiles, pharmacogenomics, food and environmental safety, genetically modified organism detection and trading, medical monitoring, diagnostic and analytical tools, and quality control. Within enabling technologies and services it primarily invests in novel packaging, process and production technologies, supply chain management, innovative materials and resources, delivery systems for active compounds, encapsulation and prevention, food services, extraction and fractionation of biological materials, consumer relation management, green biotechnology, smell and taste modifying technologies, genomics, proteomics, metabolomics, screen and characterization technologies, chemical and biological engineering, and innovative preventive and therapeutic concepts. It also invests in companies involved in the prevention of medical foods, nutraceuticals, cosmoceuticals, nutrition, innovative food, functional food, dietary and food supplements, oral and skin care, immune modulation and stimulation, and health and disease management.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 37
- Round size: Series A $2.3M–$18M; Series B $5.6M–$19M
- Lead/follow: 65% lead, 35% follow
- Last fund: May invest from a new fund soon — last raise in 2006
Portfolio highlights
- Accera — Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases. It offers Ketasyn, a molecule for Alzheimer's, Parkinson's, and age-associated memory impairment. It was founded in 2001 and is headquartered in Broomfield, Colorado.
- XOLUTION — XOLUTION is the most advanced reclosable beverage container solution. Already in its prototype state, the new XO resealable can won the Can of the Year Award in Dubai in 2009 (Winner Silver - Category Prototype) and was enhanced and refined since, involving extensive market research and field testing. With the can now entering the consumer beveragemarket, they are confident that the product resembles a step forward for XOLUTION in becoming the market leader in this field. XOLUTION GmbH is headquartered in Munich, Germany. In 2008, Marc von Rettberg was named Chief Executive of the company. He joined Christian Bratsch, Vice President R&D, to introduce innovative designs to the beverage packaging industry for reclosable beverage cans.Rettberg and Bratsch established new product design guidelines with a clear focus on values and benefits for the entire supply chain. The innovative beverage can ends were required to offer easy usage to the consumer (intuitive, easy to open and reseal), easy integration for the beverage filler in the existing processes (no major adjustments to the filling line), easy handling for the can maker (XO reclosable can ends based on standard shells), and improved commercialization for the beverage brand (unique branding options). And, of course, the focus was set on providing these benefits at a reasonable overall cost.In 2009, Can Maker Magazine recognized the XOLUTION innovative resealable can with the Silver Award in the Prototype category for the XO-400 reclosable beverage can lid. Since Time-to-Market is a key challenge for all innovators, Rettberg and Bratsch have created a competitive advantage of rapid prototyping and testing capabilities in their Salzburg R&D Center. XOLUTION GmbH is managed by one of the most competent teams in the business. With long-term experiences in their respective fields, their leading specialists guarantee the best coverage of all business areas from prototyping, R&D and product management to trading and distribution. With their knowledge, the XO Resealable Can was successfully converted from a simple vision to a technologically sophisticated product that will have a significant influence on the canned beverage market.
- Ripple Foods — Ripple Foods specializes in making non-dairy milk with just as much protein as milk and half the sugar. Ripple has 8x the protein of almond milk and half the sugar of dairy milk. It’s high in bioavailable calcium (50% more than milk), potassium and provides a good source of omega-3s. It’s lower in calories than milk and best of all, it has thecreamy, delicious texture our dairy-free friends are missing. No more thin, chalky almond/ soy/ cashew milk.It was founded in 2014 and headquartered in Emeryville, California.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Declan Magee
Show more...Investment focus
- Industry: B2B, CRM, SaaS
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Beyondbmi — Beyondbmi is an expert led medical approach to weight loss. We provide a convenient and scientific telehealth program designed to help your reach your health goals.
- SalesOptimize — Sales/Marketing professionals love our Market Intelligence & B2B Sales Lead Platform with 120M+ B2B companies and 400M+ contacts. Join Today!
WxNW operates as an investment firm.
Show more...Investment focus
- Industry: Sales, Consumer, Marketing
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
- UrbanFox — UrbanFox protects online retailers against new forms of stealth fraud by analysing and learning from existing legitimate and fraudulent customer behavioural patterns.
Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.Bpifrance was founded in 2012 and is based in Maisons-alfort, Ile-de-France,France.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: France, United States, Switzerland
Investor stats
- Total investments: 667
- Round size: Seed $643k–$5.4M; Series A $2M–$29M
- Lead/follow: 22% lead, 78% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Nonna Lab — Make the Most. Le laboratoire qui vous rend la vie meilleure.
- Altior — Altior is an IT company that offers cloud industrial management software and ERP solution.
- Umiami — Umiami Technologies is a leader in plant-based meat. Our proprietary technology allows us to create clean-label and incredibly tasty foods.
Blue Wire Capital (BWC) supports innovation by backing visionaries who want to change how the world works, primarily at pre-seed and seed. BWC provides exceptional founders and outstanding managers with fast & flexible access to capital, assistance, and a comprehensive network.
Show more...Investment focus
- Industry: Software, Art, Internet
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 29
- Round size: Seed $575k–$2.5M; Pre-Seed $550k–$4.3M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- RLTY — Metaverse Events Company
- beehiiv — Access the best tools available in email, helping your newsletter scale and monetize like never before.
- Anaphite — A breakthrough nanomaterial
Pioneering research and expertise in action. Through innovati drive new product innovation that creates value for our.
Show more...Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pure Ocean Algae — Pure Ocean Algae is a biotechnology company that integrates value chains from macro-algae and other marine resources. The company has over the winter of 2019/20 deployed its first trial lines of Palmaria palmata to sea, with initial results being extremely positive. It has also taken primary research in tank-based vegetative production andsucceeded in developing a pilot commercial plant that can produce commercial volumes of Palmaria palmata, at levels approaching 100% per week.
Conor Sheahan is the Founder and CEO of CKS Finance. He previously worked at Ocado Information Technology Limited as a Non-Executive Director. Conor Sheahan attended the Institute of Chartered Accountants in Ireland.
Show more...Investment focus
- Industry: Medical, Biopharma, Health Care
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Beyondbmi — Beyondbmi is an expert led medical approach to weight loss. We provide a convenient and scientific telehealth program designed to help your reach your health goals.
Accelerate innovation in aquaculture feed and technology.
Show more...Investment focus
- Industry: Farming, Aquaculture, Therapeutics
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- MicroSynbiotiX — Microsynbiotix, an Irish-based Biotechnology company making microalgal oral vaccines for aquaculture
Moffett Investment Holdings is an investment firm
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Series B
- Geography: Ireland
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, The Netherlands, Switzerland
Investor stats
- Total investments: 132
- Round size: Series A $6.4M–$50M; Series B $5.4M–$69M; Series C $10M–$70M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — raised $279M in 2023
Portfolio highlights
- VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
- Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
- Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
Cedas Foundation
Show more...Investment focus
- Industry: Biotechnology, Organic, Biopharma
- Stage:Seed
- Geography: Ireland, United States
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Hexafly — Hexafly is a biotechnology company that develops materials and sources form insects for aquafeed, chitin, and plant nutrition industry. It offers products from the sustainable farming of insects such as insect oil, protein, frass, and chitin. The company was founded in 2016 and headquartered in Kells, Meath, Ireland.
- BioSapien — BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline ofindications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Medtech Syndicate Nominee
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Seed, Series A
- Geography: Ireland
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Kite Medical — Kite medical has developed a novel device for detecting Kidney Reflux in children with Urinary Tract Infections. The non-invasive diagnostic solution for kidney reflux removes the need for complicated procedures and a hospital visit. Kidney reflux is the most common urological disorder in childhood, affecting up to three per cent of young children.It is most prevalent from six months to five years of age. The condition may resolve as the child gets older, but left undiagnosed and untreated it can lead to permanent kidney damage and ultimately to kidney failure.
- Signum Surgical — Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.
VisVires New Protein is a pioneering investor focused on solving the persistent challenges of our food and feed system.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Health Care
- Stage:Series A, Series B, Seed
- Geography: Israel, Germany, The Netherlands
Investor stats
- Total investments: 23
- Round size: Seed $5M–$11M; Series A $5M–$12M; Series B $5.9M–$105M
- Lead/follow: 52% lead, 48% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- In Ovo — We are on a mission to improve animal welfare in the poultry sector, and we have the technology to make it happen.
- Nuritas — Nuritas is revolutionising the discovery of novel, natural and scientifically proven active ingredients that can manage and improve human health. The company’s disruptive computational approach to discovery uses artificial intelligence and genomics to, for the first time ever, rapidly and efficiently predict and then provide access to the mosthealth-benefiting components hidden within food, called bioactive peptides.
- Collectiv Food — Collectiv Food is a next generation food supplier, helping professional kitchens through increased reliability, cost savings, and greater sustainability.
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Grant, Series C
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 109
- Round size: Grant $1.2M–$6.8M; Series C $10M–$90M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
- DataDotOrg — data.org brings together philanthropy, technology, academia, and social impact organizations to build the field of data science for social impact.
- Feinstein Institute for Medical Research — Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes ofbehavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.
Cambridge Innovation Capital backs life sciences and technology companies with an affiliation to Cambridge, Europe’s capital for innovation. As a preferred investor for the University of Cambridge, they have unparalleled access to investment opportunities in the ecosystem.Since our inception in 2013, they have raised £275 million to invest indisruptive, deep-tech businesses in sectors including, but not limited to, artificial intelligence, the internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital health, and genomics/proteomics.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 81
- Round size: Seed $614k–$13M; Series A $1.8M–$39M; Series B $6.5M–$61M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Riverlane — Riverlane's mission is to make quantum computing useful far sooner than previously imaginable, starting an era of human progress as significant as the industrial and digital revolutions.
- Mosaic Therapeutics — Mosaic Therapeutics is reshaping the interface of computational and experimental medicine to power new medicines for patients.
- Complement Therapeutics — Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Geographic atrophy (late dry age-related macular degeneration) is a chronic eye condition that affects millions - and for which there is
KBI Biopharma is an award-winning biopharmaceutical contract services organization providing fully-integrated, accelerated drug development and biomanufacturing services to pharmaceutical and biotechnology companies globally.With each of our 300+ client partners, we have worked closely to personalize and rapidly accelerate their drug developmentprograms. Built upon a foundation of world-class analytical capabilities, we deliver efficient process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs.We have locations in Durham and Research Triangle Park (NC), Boulder and Louisville (CO), The Woodlands (TX), San Diego (CA), and Leuven, Belgium.
Show more...Investment focus
- Industry: Biotechnology, Life Science, Medical
- Stage:Seed, Series A, Series D
- Geography: United States, Ireland
Investor stats
- Total investments: 3
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Absci — A better, faster path to new medicines. We translate ideas into drugs with an AI-powered approach to biologic drug discovery and cell line development.
- GlycoSeLect — GlycoSeLect Ltd specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs).
- ReForm Biologics — ReForm Biologics is an engineering superior biotherapeutic formulation for fragile patients. Its proprietary technology provides patented, FDA-friendly excipients for a wide range of therapeutic biologics. Using its platforms, drug companies can make life-saving medicines easier to administer, less immunogenic, more stable, and more efficient toproduce. It was founded in 2014 and is based in Woburn, Massachusetts.
Tekla Capital Management LLC is a registered investment adviser based in Boston, Massachusetts, and is currently the investment adviser for two closed-end equity funds, H&Q Healthcare Investors and H&Q Life Sciences Investors. The Funds invest in growth equities, both public and private, in the healthcare and life sciences industries.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series C, Series A
- Geography: United States, Switzerland, France
Investor stats
- Total investments: 49
- Round size: Series A $10M–$65M; Series B $20M–$215M; Series C $17M–$125M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Invetx — Our team of R&D leaders from human biotech and animal health is building the premier biotechnology platform for protein-based therapeutics in animal health.
- Oculis — The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME(diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. Furthermore, the technique has been demonstrated to allow diseases at the anterior part of the eye to be treated with a reduced number of topical applications compared to conventional eye-drops.
- Amolyt Pharma — We are building on our team's established expertise in therapeutic peptides to deliver life-changing treatments to patients suffering from rare endocrine and metabolic diseases.
Street Capital Financial Corporation is a Canadian wholesale lending company. As a wholesale lender, Street Capital doesn’t have an expensive branch network and as such can pass those savings to the consumer. Street Capital prides itself on offering consumers competitive products and interest rates with an exceptional level of service.Havingapproved lender status with Canada Mortgage and Housing Corporation (CMHC) Street Capital is able to offer a broad spectrum of residential mortgage financing products to the consumer. Also, since we’re primarily focused on the mortgage broker origination channel, you’re assured that your mortgage will fit your needs comfortably.By continually working to develop innovative lending solutions and working in partnership with your local mortgage brokers, Street Capital is proud to help more Canadians realize their dreams of home ownership and enhancement.
Show more...Investment focus
- Industry: Medical, Automotive, Biotechnology
- Stage:Seed
- Geography: Ireland, United States
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Biosensia — Biosensia is a Point-of-Care in-vitro diagnostics company that has a novel point-of-care platform, RapiPlex, available for licensing. RapiPlex combines highly innovative technologies to produce a practical, rapid, multiplexing POC in-vitro diagnostics (IVD) platform, enabling access to a broad range of diagnostic applications. Its componentchip and cartridge system are compatible with a variety of common biological sample types, including whole blood, serum, saliva, urine and nasal/genital swabs.
- Drive Time Metrics — Drive Time Metrics is developing innovative new revenue streams from connected car data, and helping automotive OEMs monetize their connected vehicle platforms.
ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, China, Canada
Investor stats
- Total investments: 297
- Round size: Series A $7M–$100M; Series B $14M–$230M; Series C $12M–$104M
- Lead/follow: 25% lead, 75% follow
- Last fund: Likely still investing — raised $3B in 2022
Portfolio highlights
- Bitterroot Bio — Bitterroot Bio is pioneering the emerging field of cardio-immunology, which investigates the interplay between the immune system and cardiovascular health.
- Orbital Therapeutics — Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease in ways that were not previously possible.
- Rapport Therapeutics — Precision medicines to match the complexity of the human brain.
Discover start-up investing made simple. Access VC-led rounds, build your portfolio, and unlock growth at Ascentifi
Show more...Investment focus
- Industry: Medical Device, Medical, Hospital
- Stage:Series A
- Geography: Ireland
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
- Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
Founded in 1997, Earlybird invests in all development and growth phases of technology companies. Among the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources but also strategic support plus access to an international network and capital markets. With EUR 2 billion under management,eight IPOs and 30 trade sales, Earlybird is one of the most established and active venture capital firms in Europe.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Series A, Seed, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 247
- Round size: Seed $1.2M–$14M; Series A $2M–$26M; Series B $4.8M–$40M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Binalyze — Binalyze enhances all your digital forensics and incident response processes at max speed.
- ColibrITD — Quantum Computing Software Algorithm
- Re-Fresh Global — Re-Fresh Global brings sustainability innovation into the manufacturing industry. Our patented biotechnology transforms textile waste into recycled raw materials: nanocellulose, ethanol, and sanitized textile pulp.
Biotechnology Investor funding in Ireland at a glance
Stats across 147 deals from 150 investors.
Access all 150 investors in Ireland Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology Investors in Ireland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 150 investors investing in Ireland Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!